Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Are histones real pathogenic agents in sepsis?

Subjects

We thank Ginsburg and Koren for their brief overview of the potential role of extracellular histones in the pathogenesis of sepsis (Ginsburg,I.&Koren,E.Arehistonesrealpathogenicagentsinsepsis?Nat.Rev.Immunol.http://dx.doi.org/10.1038/nri.2017.156(2017))1. Although our Review article (The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407–420 (2017))2 covers a variety of immunological changes and mechanisms implicated in sepsis pathogenesis, the space allowed was not unlimited. We therefore chose to discuss damage-associated molecular patterns (DAMPs) in a general way, stating that “During sepsis, the host response is further disrupted owing to the release of ... DAMPs ... . DAMPs can activate many of the PRRs [pattern recognition receptors] that also recognize PAMPs [pathogen-associated molecular patterns], giving rise to a vicious cycle that also involves sustained immune activation and organ dysfunction” and “PRRs interact with diverse PAMPs and DAMPs, and this diversity can probably explain the similarity between the inflammatory reactions induced by different pathogens and ... different types of injury, either infectious or non-infectious” (Ref. 2). We cited two Reviews from major journals to support these statements3,4, and included the role of DAMPs in sepsis pathogenesis in figure 1. Since we fully agree that reporting should be unbiased, we would like to point out that besides histones, many other DAMPs have been implicated in sepsis pathogenesis. To name a few: high-mobility group box 1 (Ref. 5), S100A8–S100A9 (Refs 6,7), cold-inducible RNA binding proteins8, mitochondrial DNA9, heat shock proteins, IL-1α and IL-33 (Refs 10,11). Other important topics unfortunately could also not be discussed in our Review, including mitochondrial dysfunction12,13, oxidative stress12,13, resolution of inflammation (with the role of bioactive lipids such as lipoxins and resolvins therein)14 and the mechanisms that could contribute to late sequelae of sepsis15. The pathogenesis of sepsis is extremely complex and variable, depending on the pathogen (load and virulence), the host (genetics, epigenetics and comorbidity), the environment (including the microbiome) and the time elapsed after the start of the infection, with distinct host responses at local, regional and systemic levels. In this respect, as we tried to accentuate in our Review, it remains unclear which mechanisms are the main drivers of sepsis-associated pathology in time.

References

  1. Ginsburg, I. & Koren, E. Are histones real pathogenic agents in sepsis? Nat. Rev. Immunol. http://dx.doi.org/10.1038/nri.2017.156 (2017)

  2. van der Poll, T. et al. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407–420 (2017).

    CAS  Article  Google Scholar 

  3. Chan, J. K. et al. Alarmins: awaiting a clinical response. J. Clin. Invest. 122, 2711–2719 (2012).

    CAS  Article  Google Scholar 

  4. Deutschman, C. S. & Tracey, K. J. Sepsis: current dogma and new perspectives. Immunity 40, 463–475 (2014).

    CAS  Article  Google Scholar 

  5. Andersson, U. & Tracey, K. J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29, 139–162 (2011).

    CAS  Article  Google Scholar 

  6. Vogl, T. et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042–1049 (2007).

    CAS  Article  Google Scholar 

  7. van Zoelen, M. A. et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am. J. Respir. Crit. Care Med. 180, 1098–1106 (2009).

    CAS  Article  Google Scholar 

  8. Qiang, X. et al. Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis. Nat. Med. 19, 1489–1495 (2013).

    CAS  Article  Google Scholar 

  9. Boyapati, R. K. et al. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res 6, 169 (2017).

    Article  Google Scholar 

  10. Xu, H. et al. Role of the IL-33-ST2 axis in sepsis. Mil. Med. Res. 4, 3 (2017).

    Article  Google Scholar 

  11. Kang, J. W. et al. DAMPs activating innate immune responses in sepsis. Ageing Res. Rev. 24, 54–65 (2015).

    CAS  Article  Google Scholar 

  12. Singer, M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 5, 66–72 (2014).

    Article  Google Scholar 

  13. Arulkumaran, N. et al. Mitochondrial function in sepsis. Shock 45, 271–281 (2016).

    CAS  Article  Google Scholar 

  14. Buechler, C., Pohl, R. & Aslanidis, C. Pro-resolving molecules - new approaches to treat sepsis? Int. J. Mol. Sci. 18, E476 (2017).

    Article  Google Scholar 

  15. Shankar-Hari, M. & Rubenfeld, G. D. Understanding long-term outcomes following sepsis: implications and challenges. Curr. Infect. Dis. Rep. 18, 37 (2016).

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Tom van der Poll.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

van der Poll, T., van de Veerdonk, F., Scicluna, B. et al. Are histones real pathogenic agents in sepsis?. Nat Rev Immunol 18, 148 (2018). https://doi.org/10.1038/nri.2017.157

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nri.2017.157

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing